Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma

Antibodies targeting the programmed cell death protein-1 (PD-1) molecule have been reported to hold promising antitumor activities in patients with nasopharyngeal carcinoma (NPC). However, only a small subset of NPC patients benefits from the anti-PD-1 monotherapy and factors that affect the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liqin, Ma, Yuxiang, Fang, Chao, Peng, Zhuobing, Gao, Fangfang, Moll, Janne Marie, Qin, Shishang, Yu, Qichao, Hou, Yong, Kristiansen, Karsten, Fang, Wenfeng, Brix, Susanne, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428750/
https://www.ncbi.nlm.nih.gov/pubmed/36059644
http://dx.doi.org/10.3389/fonc.2022.953884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428750/
https://www.ncbi.nlm.nih.gov/pubmed/36059644
http://dx.doi.org/10.3389/fonc.2022.953884

Ejemplares similares